Embria Health Sciences, Ankeny, IA, and B&D Nutritional Ingredients, Vista, CA, have signed an extension to their distribution agreement, granting exclusive rights to market and sell EpiCor throughout the U.S. The extended distribution agreement builds on an existing collaboration between the two company groups, which resulted in a successful launch of the product in the U.S. and a previous extension of the distribution agreement in 2010.
 
EpiCor is a natural fermentation ingredient composed of dozens of compounds and metabolites that work together to help strengthen the immune system by balancing immune response.
 
“As consumers of all ages increasingly desire a stronger immune system, our customers are looking for proven and consumer-focused ingredients to help their customers,” said Bill Van Dyke, CEO and chairman of B&D Nutritional Ingredients. “EpiCor is clearly a one-of-a-kind, effective ingredient that consumers are adopting into their lifestyle every day and gives our customers an essential and profitable tool for achieving their goals in every environment.”
 
“B&D has been a critical alliance for us. Partnering with them has enabled us to expand our reach to far more manufacturers,” said Paul Faganel, president of Embria Health Sciences. “We appreciate Bill and his team’s dedication to the industry. His highly competent staff has effectively portrayed EpiCor’s multifaceted benefits to the marketplace. Our partnership with B&D reinforces the value EpiCor delivers to dietary supplement manufacturers to create products proven to strengthen the immune system, which is a highly desirable consumer benefit.”